Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Liver failure in a patient treated with long-term rosiglitazone therapy.

× No keyword cloud information.

9 in total

1. Cytotoxicity of 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione (DCPT) and analogues in wild type and CYP3A4 stably transfected HepG2 cells.

Authors: Douglas M Frederick; Erina Y Jacinto; Niti N Patel; Thomas H Rushmore; Ruy Tchao; Peter J Harvison
Journal: Toxicol In Vitro Date: 2011-09-22 Impact factor: 3.500

Review 2. Important elements for the diagnosis of drug-induced liver injury.

Authors: Vijay K Agarwal; John G McHutchison; Jay H Hoofnagle
Journal: Clin Gastroenterol Hepatol Date: 2010-02-17 Impact factor: 11.382

3. Improvement of abnormal liver enzymes after rosiglitazone treatment in Chinese type 2 diabetes.

Authors: Jing-Quan Zheng; Kun Wang; Dee Pei; Yen-Lin Chen; Yen-Lin Chang; Chun-Hsien Hsu; Tsan-Ming Huang; Mei-Yu Lin; Pao-Ying Lin; Jiunn-Diann Lin
Journal: Indian J Pharmacol Date: 2012-05 Impact factor: 1.200

4. Effect of structural modifications on 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione-induced hepatotoxicity in Fischer 344 rats.

Authors: Niti N Patel; Christine M Crincoli; Douglas M Frederick; Ruy Tchao; Peter J Harvison
Journal: J Appl Toxicol Date: 2011-02-21 Impact factor: 3.446

5. Effect of gender, dose, and time on 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione (DCPT)-induced hepatotoxicity in Fischer 344 rats.

Authors: N N Patel; C M Crincoli; E L Kennedy; D M Frederick; R Tchao; P J Harvison
Journal: Xenobiotica Date: 2008-04 Impact factor: 1.908

Liver failure in a patient treated with long-term rosiglitazone therapy.

1. Cytotoxicity of 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione (DCPT) and analogues in wild type and CYP3A4 stably transfected HepG2 cells.

Review 2. Important elements for the diagnosis of drug-induced liver injury.

3. Improvement of abnormal liver enzymes after rosiglitazone treatment in Chinese type 2 diabetes.

4. Effect of structural modifications on 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione-induced hepatotoxicity in Fischer 344 rats.

5. Effect of gender, dose, and time on 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione (DCPT)-induced hepatotoxicity in Fischer 344 rats.

6. Liver Injury with Features Mimicking Autoimmune Hepatitis following the Use of Black Cohosh.

Review 7. Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus.

8. Role of biotransformation in 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione-induced hepatotoxicity in Fischer 344 rats.

Review 9. Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence.